Finance

David Einhorn’s eclectic portfolio shuns AI, bets on consumer, healthcare

Greenlight Capital boss David Einhorn loaded up on cash-flow–driven names in Q4 2025, buying Graphic Packaging, Capri Holdings, and various healthcare stocks while dialing back AI beneficiaries. He also opened a new stake in Global Payments, signaling a cautious tilt away from AI hype toward durable, non-AI revenue streams.

David Einhorn’s eclectic portfolio shuns AI, bets on consumer, healthcare

Key Takeaways

  • Q4 2025 purchases included Graphic Packaging, Capri Holdings and multiple healthcare stocks amid AI-overvaluation concerns.
  • New stake in Global Payments signals a shift toward AI-resistant, cash-flow–driven businesses.
  • Graphic Packaging (GPK) and Capri Holdings (CPRI) rose, elevating them among Greenlight’s top holdings per Insider Score.
  • Acadia Healthcare (ACHC) rose ~150% to over $58M, despite a 43% Q4 2025 share drop; CNC and HSIC also saw meaningful action.
  • Teva (TEVA) and Roivant (ROIV) positions were reduced; Global Payments (GPN) stake around $35M with mixed 2025/2026 performance.

People Involved

  • David Einhorn Founder and CEO, Greenlight Capital
  • Debbie Osteen CEO, Acadia Healthcare

Entities Involved

  • Graphic Packaging International, Inc. (GPK) Packaging company
  • Capri Holdings (CPRI) Fashion and luxury goods group
  • Global Payments Inc. (GPN) Payments processor
  • Acadia Healthcare (ACHC) Healthcare services provider
  • Centene Corp. (CNC) Health insurer
  • Henry Schein, Inc. (HSIC) Medical supplies distributor and services
  • Teva Pharmaceutical Industries Ltd. (TEVA) Pharmaceutical company
  • Roivant Sciences Ltd. (ROIV) Biotech company
  • Insider Score Data/valuation methodology referenced for top holdings

MarketMoodz Analysis

The moves underscore a disciplined value approach in an AI-tilted market: Einhorn is leaning into companies with visible cash flows and durable demand, countering the frenetic pace of AI-driven narratives.

From a historical perspective, Einhorn’s stance echoes a classic value play amid tech exuberance—seek balance between growth stories and predictability of earnings in sectors like consumer staples, healthcare, and payments that can weather AI disruption.

Investors should watch follow-on 13F filings and subsequent quarterly results to gauge whether this tilt toward AI-resilient businesses sustains and whether the AI hype cycle continues to distort broader valuations in software and semiconductor names.

Get AI-Powered Market Insights

Stay ahead of market-moving events with our real-time analysis and stock ratings.

Start Your Free Trial